AI

Bridging the gap: artificial to biological neuron interfacing

Is non-binary the way forward for BCI (brain computer interfacing)? Chemical computing could be a powerful tool in combating aging. Dopamine is known for playing...

Easy-peasy Series-B(sy)

Nuritas launches PeptiYouth™ an AI-discovered peptide, clinically proven, anti-aging molecule. Nuritas, a leader in Artificial Intelligence-based peptide discovery, has launched PeptiYouth™, a peptide discovered within peas and which, following clinical trials, has been shown...

Partnership demonstrates government Longevity intervention

PAI Health to support UK's All-Party Parliamentary Group for Longevity in its quest to extend life expectancy and minimise health inequality. Digital health technology company...

Inside is the new outside for DNA and PT collaboration

Working your core means going even deeper - right down to your genes - thanks to PT Hub and Muhdo Health. Biohacking – DIY Biology...

Microbiome clock has the guts to tell your age

Insilico and Harvard develop the first AI-powered microbiomic aging clock. Scientists from Harvard Medical School and Insilico Medicine have used thousands of whole genome sequencing samples...

‘Internet of the body’ device to regulate genes externally

Bioelectric remote control of cell signalling drives synthetic biology progress: tests trigger bioengineered cells to release insulin. A team at the Department of Biosystems Science and...

Machine learning to de-risk clinical trials

Insilico and Oxford University used machine learning to predict major clinical forms of drug cardiotoxicity. Insilico Medicine announced this week that they, in partnership with...

Move over AI? Here comes biological intelligence

Braincures raising funds to take-on AI drug discovery for Alzheimer’s and other neurological diseases with data analysis and systems biology. The treatment of neurological diseases...

Fountain’s ‘hypothesis-free’ approach to Longevity AI

We reached out to Fountain’s CEO John Dimos to see what more we can learn about the mysterious San Francisco start-up. When it comes to...

G3 and Juvenescence partner on deep learning venture

G3 Therapeutics and Juvenescence announce the formation of Juvenomics to apply deep molecular profiling and deep learning to tackle aging. Juvenomics, a joint venture between...

New benchmark for senescence developed from CellAge database

Comprehensive cellular senescence database will provide benchmark for the development of senolytic therapies. Our cells are intrinsically programmed for senescence – a gradual aging and...

Real-time tracking of 400+ Longevity biomarkers

Longevity InTime aims to track 400+ biomarkers of health in ‘real time’ ... starting with millionaires (as both users and investors). From wearable devices and...

Biomarkers for aging – a consensus is needed now more than ever

Slowing, stopping and even reversing aging – how can we research progress if we can't measure success? Biomarkers of aging are pretty important in the...

Hereafter: conversations in the afterlife

We speak to Dadbot creator James Vlahos about using conversational AI to better remember loved ones who have passed away; a very interesting step...

VR and AI used to generate structures to attack Coronavirus

Virtual reality and artificial intelligence come together to generate new chemicals from scratch which could be used against SARS-CoV-2. A new paper has outlined...

Longevity and the Singularity

Consciousness in the cloud? Where science fact and fiction collide. While the principle focus of Longevity is undoubtedly the extension of healthy human lifespan, there...

Longevity Leaders World Congress goes virtual

Annual Longevity conference gets a digital makeover as the community adapts to COVID-19. With much of the world still in some form of lockdown, the...

Making the Longevity grade: expanded list of 1000 leading names

2020 list showcases a growing network of Longevity influencers from the worlds of aging research, technology, policy, media and investment. Who's who in Longevity? Following-on...

Applying theoretical physics to Longevity drug discovery

Peter Fedichev's Gero raising $10 million for anti-aging drug discovery and clinical trials. The use of AI in Longevity drug discovery is nothing new, Insilico...

Google on the rise! Yeast is key to Longevity research

It's common knowledge that experiments on mice or pigs, could hold the key to developments in the aging sphere. But, how about yeast? Google...

Latest articles

Selfie biomarkers: AI and insurtech implications for Longevity

AI firm Lapetus targets the face as a biomarker of aging: one simple picture can open-up a host of opportunities and implications. Wow. Named after...

Low levels of stress hormone contributes to aging

When it comes to the stress hormone cortisol, balance is everything, according to a new study in Germany.  There have been plenty of studies that...

Rejuvenation Roadmap charts life extension progress

We take a trip down Lifespan.io's Rejuvenation Roadmap – and it's a journey towards Longevity progress. Lifespan.io is a US-based non-profit organisation that seeks to...

Longevity therapies delivered through skin is a topical issue

Non-invasive therapy that comes in a bottle could be the Longevity crème de la crème. Therapeutic substances like arnica, turmeric and witch hazel have been...